Dermatology最新文献_第2页

Prevalence of Hidradenitis Suppurativa in the Gulf Province of Papua New Guinea. 巴布亚新几内亚海湾省化脓性汗腺炎的流行情况。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000538422

Nadja E Zorge, Johanna C van Huijstee, Jasper S Dijkema, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Errol P Prens, Hessel H van der Zee

{"title":"Prevalence of Hidradenitis Suppurativa in the Gulf Province of Papua New Guinea.","authors":"Nadja E Zorge, Johanna C van Huijstee, Jasper S Dijkema, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Errol P Prens, Hessel H van der Zee","doi":"10.1159/000538422","DOIUrl":"10.1159/000538422","url":null,"abstract":"Introduction: Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory skin disease, which mostly occurs in the skinfolds. The global prevalence of HS is currently unknown. Depending on the type of research and studied population, the reported prevalence varies between 0.03% and 4.1%. It is important to investigate the prevalence of HS worldwide using the same study design, in order to recognize, diagnose, and treat patients at an earlier stage. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA) has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. The prevalence of HS in a Pacific Islander population has not been reported. The aim of this study was to estimate the prevalence of HS in Kapuna, Papua New Guinea.Methods: An explorative, descriptive, cross-sectional mono-center study in a secondary care center, the Kapuna Hospital, Papua New Guinea. Participants were healthy persons accompanying patients who were admitted to Kapuna Hospital or attending its Outpatient Department, and healthy hospital staff. The primary outcome of this study was the point prevalence of HS in Papua New Guinea using a validated questionnaire and physical examination.Results: A total of 520 participants were included in this study. The prevalence of HS in these 520 participants was 0.38% (2/520, 95% confidence interval 0.1-1.4%).Conclusion: The point prevalence of HS in Papua New Guinea was 0.38%. The findings of this study contribute to fill a gap in the current insights into global HS prevalence.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire. 希腊雅典化脓性汗腺炎的流行：一项基于有效问卷的横断面研究。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000539758

Theodora Kanni, Sofia Ktena, Konstantinos Leventogiannis, Christina Damoulari, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Evangelos J Giamarellos-Bourboulis

{"title":"Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire.","authors":"Theodora Kanni, Sofia Ktena, Konstantinos Leventogiannis, Christina Damoulari, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Evangelos J Giamarellos-Bourboulis","doi":"10.1159/000539758","DOIUrl":"10.1159/000539758","url":null,"abstract":"Introduction: Prevalence of hidradenitis suppurativa (HS) differs between countries and the worldwide prevalence of the disease remains unknown. Prevalence of HS has never been studied in Greece. The aim of this study was to estimate the HS prevalence in Athens, the capital of Greece.Method: Healthy adults accompanying patients to the outpatient department of internal medicine of ATTIKON University Hospital were approached by physicians familiar with HS. All eligible persons signed an informed consent form and answered the questionnaire. This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative and therefore followed the objective and approach previously published by Bouazzi et al. [Dermatology. 2024 Feb;240(3):369-75].Results: Out of 553 participants, 20 screened positive for HS. Of these, only one was diagnosed with HS, resulting in a prevalence of 0.18% (95% CI, 0.03%-1.02%). The sensitivity of the HS questionnaire was 100%, specificity 75.9%, positive predictive value 5.0%, and negative predictive value 100%.Conclusion: The prevalence of HS in our study was relatively low. A further study with a larger number of participants is needed to confirm the findings.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative. 瑞典隆德和哥德堡的化脓性汗腺炎患病率：来自全球化脓性汗腺炎地图集倡议的分析。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000539706

Anja Pahlow Mose, Karin Arvidsson, Karin Nyberg, Dorra Bouazzi, Robin Christensen, Gregor B E Jemec, Victoria Marmgren

{"title":"Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative.","authors":"Anja Pahlow Mose, Karin Arvidsson, Karin Nyberg, Dorra Bouazzi, Robin Christensen, Gregor B E Jemec, Victoria Marmgren","doi":"10.1159/000539706","DOIUrl":"10.1159/000539706","url":null,"abstract":"Introduction: Epidemiologic studies of hidradenitis suppurativa (HS) from Sweden are limited. The aim of this study was to investigate the prevalence of HS in Lund and Gothenburg, Sweden.Methods: This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The study was multicentered and included apparently healthy adults accompanying a patient to the Department of either Endocrinology or Ophthalmology in a Swedish University Hospital from February 1 to November 30, 2023. Recruitment occurred in the waiting rooms where the study participants were consecutively invited to answer a validated screening questionnaire which had been translated into Swedish. In the questionnaire, the key screening questions asked were whether the study participant had had 2 or more boils/abscesses in the past 6 months and if these were in any of the typical skin sites for HS. Screen-positive and randomly selected screen-negative participants were clinically examined for HS by a dermatologist to verify the results.Results: A total of 551 accompanying adults were approached of which 505 answered the questionnaire. The prevalence of HS in this sample was 0.99% (95% confidence interval [0.43%-2.30%]). There was a statistically significant difference in BMI between the HS and control group, but not in relation to age or sex.Conclusion: HS appears to be a common chronic disease in Sweden. Also, there is a strong association between overweight/obesity and HS.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Saudi Arabia. 沙特阿拉伯化脓性汗腺炎的流行情况。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000538727

Yousef Binamer, Ola Samman, Anwar Aldabagh, Jwana Boushi, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec

{"title":"Prevalence of Hidradenitis Suppurativa in Saudi Arabia.","authors":"Yousef Binamer, Ola Samman, Anwar Aldabagh, Jwana Boushi, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec","doi":"10.1159/000538727","DOIUrl":"10.1159/000538727","url":null,"abstract":"Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition. The prevalence of HS is underreported worldwide; moreover, the epidemiological studies about HS in Saudi Arabia are scarce. Therefore, this study was performed to explore the prevalence in Saudi Arabia.Methods: This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. This study was a single-center study in tertiary care center in Riyadh, Saudi Arabia. All relevant data were collected after obtaining a written informed consent, and data were analyzed accordingly. The study was conducted between March and May 2023. The participants were healthy adults accompanying a child or adult in internal medicine or pediatrics outpatient clinics. The diagnosis was done clinically by an expert physician.Results: In total, 688 individuals were included; the estimated prevalence of HS is a minimum of 4.07% within the sample. The utilized questionnaire has a sensitivity of 100% and a specificity of 15%.Conclusion: The high prevalence of HS in Saudi population necessitates more education to the community and health care providers for early diagnosis and management.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka. 斯里兰卡巴兰哥达地区化脓性汗腺炎的流行情况。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000539336

Kanchana Viraj Mallawaarachchi, Chathurika Gangani, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec

{"title":"Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.","authors":"Kanchana Viraj Mallawaarachchi, Chathurika Gangani, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec","doi":"10.1159/000539336","DOIUrl":"10.1159/000539336","url":null,"abstract":"Introduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicles in the apocrine gland-bearing areas of the body. The global HS prevalence has been reported in the range of 0.00033-4.1%. It is reportedly rarer in Asia.Methods: The study aimed to establish the prevalence of hidradenitis suppurativa (HS) in a Sri Lankan hospital setting. An explorative, cross-sectional, descriptive study was done on a sample of accompanying healthy persons to patients at Base Hospital, Balangoda, Sri Lanka. The study was conducted over a 6-month period (November 1st, 2022, to April 30th, 2023) and was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The data were collected using validated self-administered questionnaire. When the questionnaire indicated HS (screen-positive), the study participant was referred to the consultant dermatologist, who examined the individual and confirmed the final diagnosis based on three obligatory diagnostic criteria (i.e., typical lesion, typical topography, and the chronicity and recurrence).Results: Of 993 participants, the prevalence of HS was 0.2 (95% confidence interval 0.06%-0.73%). The difference in median age between two groups (i.e., individuals with HS - positive group and the control group) was statistically significant (p = 0.01802). The HS group was relatively younger with a median age of 26.5 (23.8-29.3) years, while that of the control group was 54.0 (48.0-59.0).Conclusion: Hidradenitis suppurativa is rare in Sri Lanka as in other Asia-pacific countries.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire. 比利时布鲁塞尔化脓性汗腺炎的流行：筛选问卷的验证。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000539477

Fadwa El Aissoug, Wassila Bouazza, Hassane Njimi, Joelle Feghali, Véronique Del Marmol, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Farida Benhadou

{"title":"Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire.","authors":"Fadwa El Aissoug, Wassila Bouazza, Hassane Njimi, Joelle Feghali, Véronique Del Marmol, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Farida Benhadou","doi":"10.1159/000539477","DOIUrl":"10.1159/000539477","url":null,"abstract":"Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent and debilitating skin disease, with a poorly understood global burden. The prevalence of HS in Belgium is not yet known. We aimed to determine the prevalence of the disease in the Belgian context and validate a screening questionnaire.Materials and methods: Conducted as part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative, this monocenter cross-sectional study involved 500 healthy adults accompanying patients at the Erasme Hospital in Brussels. Participants gave their consent and completed a screening questionnaire. All screen-positive and a subset of some screen-negative participants underwent clinical examination by a dermatologist. The severity of the disease was assessed using the Hurley staging.Results: The prevalence of HS in the sample was 1.6% (8/500; 95% Cl: 0.81%-3.13%). There were no statistically significant demographic differences between the group control and the HS group. The screening questionnaire demonstrated a sensitivity of 100%, a specificity of 89%, a positive predictive value of 56% and a negative predictive value of 100%. Most of the patients diagnosed with HS were Hurley I (6/8) and the axilla was the most affected area.Conclusion: The study uncovered a 1.6% prevalence of HS among a cohort of 500 Belgian participants and contributed to the GHiSA project. The high sensitivity and specificity of the screening questionnaire suggests it is an effective tool for detecting HS in the general population.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Darmstadt, Germany: A Contribution to the Global Hidradenitis Suppurativa Atlas. 德国达姆施塔特化脓性汗腺炎的流行：对全球化脓性汗腺炎地图集的贡献。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000539285

Marten I Steinmetz, Dorra Bouazzi, Maximilian Kovács, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Maurizio Podda

{"title":"Prevalence of Hidradenitis Suppurativa in Darmstadt, Germany: A Contribution to the Global Hidradenitis Suppurativa Atlas.","authors":"Marten I Steinmetz, Dorra Bouazzi, Maximilian Kovács, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Maurizio Podda","doi":"10.1159/000539285","DOIUrl":"10.1159/000539285","url":null,"abstract":"Introduction: The knowledge of the epidemiology of hidradenitis suppurativa (HS) in Germany is currently insufficient. This study aimed to determine the prevalence of HS in Darmstadt, Germany, and contribute to the Global Hidradenitis Suppurativa Atlas (GHiSA).Methods: This monocentric, cross-sectional study was conducted at the Klinikum Darmstadt, Germany, from January to February 2024. Data from 519 healthy accompanying adults were included after obtaining oral and written consent. A validated screening questionnaire, used as an index test before clinical examination, was performed on screening-positive and randomly selected screening-negative participants as a reference test.Results: The prevalence of HS in Darmstadt, Germany, was 1.16% (6/519; confidence interval: 0.95: 0.53%-2.50%). The HS group had a median age of 37.5 years and a median BMI of 32.5. No predominance of sex or smoking status could be found in the HS group and there were no statistical differences between the groups in sex, age, or smoking status. However, the median BMI was significantly higher in the HS group.Conclusion: The study found the prevalence of HS in Darmstadt, Germany, to be 1.16%, which is significantly higher than previously reported rates in Germany. This study found an association between BMI and HS. However, it did not observe the previously reported association between HS and sex or smoking status. The questionnaire used is a valid screening tool for HS in the assessment of the general population.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa. 南非夸祖鲁-纳塔尔省德班地区化脓性汗腺炎的流行情况。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000543025

Haroon Saeed, Ameshin Moodley, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Dorra Bouazzi, Anisa Mosam

{"title":"Prevalence of Hidradenitis Suppurativa in Durban, KwaZulu-Natal South Africa.","authors":"Haroon Saeed, Ameshin Moodley, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Dorra Bouazzi, Anisa Mosam","doi":"10.1159/000543025","DOIUrl":"10.1159/000543025","url":null,"abstract":"Introduction: Hidradenitis suppurativa (HS) is a chronic, debilitating condition that is underrecognized and poorly managed in South Africa. Hence, this study aimed to determine the prevalence of HS in KwaZulu-Natal, South Africa.Methods: This multicenter, explorative, cross-sectional, and descriptive study was conducted on 500 persons accompanied by patients in a tertiary and private hospital in Ethekwini, KZN, South Africa, from 6th February to 16th March 2023. After obtaining consent, they were screened by a physician for HS on a validated questionnaire comprising questions for the presence of recurrent painful deep-seated boils in the axillae, breasts, groins, or perineum. Screened positive and selected (10%) negative persons were re-examined by a dermatologist. Relevant data on demographics, smoking, and body mass index (BMI) were also collected.Results: From 500 participants, 9 were confirmed as HS and the point prevalence was 1.8%. The HS group comprised 8 females and 1 male, with a median interquartile range age of 36 years (IQR 29-42) and BMI of 27.3 kg/m2 (IQR 26.8-29.9). Four HS patients were of African ethnic origin (44.4%), and 5 were of Asian ethnic origin (55.6%). The majority of HS cases were graded as Hurley stage I (7/9 cases) and 2 were Hurley stage III. The sensitivity from the HS questionnaire was 100% and the specificity was 80%. The positive predictive value was 0.4 while the negative predictive value was 1.0.Conclusion: The prevalence of HS in KwaZulu-Natal South Africa is 1.8%, with those of African and Indian ethnicity being more predisposed.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA). 荷兰化脓性汗腺炎的患病率：作为全球化脓性汗腺炎地图集（GHiSA）一部分的横断面研究。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000542816

Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, Cecilia E Medianfar, Gregor B E Jemec, Robin Christensen, Pim Aarts, Raveena A Mangal, Beyza Erdal, Nienke C T Geraedts, Errol P Prens, Hessel H van der Zee

{"title":"Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).","authors":"Johanna C van Huijstee, Kelsey R van Straalen, Dorra Bouazzi, Cecilia E Medianfar, Gregor B E Jemec, Robin Christensen, Pim Aarts, Raveena A Mangal, Beyza Erdal, Nienke C T Geraedts, Errol P Prens, Hessel H van der Zee","doi":"10.1159/000542816","DOIUrl":"10.1159/000542816","url":null,"abstract":"Introduction: The global prevalence of the chronic and debilitating skin disease hidradenitis suppurativa (HS) is currently unknown. Depending on the research type and the studied population, reported prevalence rates for HS range from 0.03% to 4.1%. It is crucial to investigate the global prevalence of HS using a standardized study design to facilitate earlier recognition, diagnosis, and treatment of patients. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA), has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. In cooperation with this initiative, this study aimed to investigate the prevalence of HS in the Netherlands.Methods: An explorative, descriptive, cross-sectional mono-center study was conducted at the Ear Nose Throat and Internal Medicine department of the Erasmus Medical Center. Healthy adults accompanying patients undergoing care in a hospital setting were asked to fill out a validated questionnaire and undergo physical examination. Primary outcome was the point prevalence of HS.Results: In total, 663 participants were included in this study. Overall, the prevalence of HS was 0.60% (4/663, 95% confidence interval 0.32%-1.54%).Conclusion: The point prevalence of HS in the Netherlands is 0.60%. This study is part of a global initiative; therefore, data can be incorporated in a worldwide analysis of the HS prevalence.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-6"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria. 尼日利亚阿布贾健康成人中化脓性汗腺炎的患病率。

IF 3 3区医学

Dermatology Pub Date : 2025-07-07 DOI: 10.1159/000539443

Perpetua U Ibekwe, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec

{"title":"Prevalence of Hidradenitis Suppurativa among Healthy Adults in Abuja, Nigeria.","authors":"Perpetua U Ibekwe, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec","doi":"10.1159/000539443","DOIUrl":"10.1159/000539443","url":null,"abstract":"Introduction: Hidradenitis suppurativa (HS) is an inflammatory disorder that affects the apocrine gland-bearing regions. There is currently no population-based study of HS in Nigeria. The purpose of this study was to investigate the prevalence of HS in Abuja, Nigeria's federal capital territory.Methods: This is a cross-sectional study of healthy adults accompanying patients to the outpatient clinics of the tertiary hospital in Abuja, utilizing the Global Hidradenitis Suppurativa Atlas (GHiSA) questionnaire as part of the GHiSA program.Results: The prevalence of HS in 898 participants was 3.3% (95% confidence interval (CI): 2.3%-4.7%). Participants with HS had a significantly higher body mass index than those without (p value of 0.038). One out of the 30 HS participants had a Hurley score of 2, while the rest had a Hurley score of 1. The majority of participants (49%) exhibited HS symptoms involving the axilla. The GHiSA questionnaire has a sensitivity rate of 93.8% (95% CI: 79.2%-97.3%) and a specificity rate of 93.8% (95% CI: 88.2%-97.3%).Conclusion: The prevalence of HS in our study (3.3%) was higher than that seen in hospital records (0.47%). This demonstrates that most HS patients present to the dermatology outpatient clinics when the disease is severe.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233965/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144583353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0